Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
Satralizumab demonstrated superior efficacy in reducing NMOSD relapse rates compared to conventional immunosuppressants while maintaining a comparable safety profile.
Authors
- Lianshun Lin
- Sheng‐Feng Lin (ORCID: https://orcid.org/0000-0003-0470-2184)
- H.‐J. Lin (ORCID: https://orcid.org/0000-0002-0661-173X)
Institutions
- Taipei Medical University Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1002/acn3.70246
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Ministry of Education, India